List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 63 studies with search of:   Australia, Australian Capital Territory
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: cetuximab;   Drug: Irinotecan;   Drug: Irinotecan
2 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
3 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
4 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
5 Completed RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
6 Completed Oral Direct Factor Xa-Inhibitor Apixaban in Patients With Acute Symptomatic Deep-Vein Thrombosis-The Botticelli DVT Study
Condition: Deep-Vein Thrombosis
Intervention: Drug: Apixaban
7 Active, not recruiting Study of BAY 43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Conditions: Cancer;   Carcinoma, Renal Cell
Interventions: Drug: Nexavar (Sorafenib, BAY 43-9006);   Drug: Placebo
8 Recruiting A Study of Abatacept in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: abatacept;   Drug: placebo
9 Active, not recruiting Caffeine for Apnea of Prematurity (CAP)
Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
10 Recruiting Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Condition: Sepsis
Interventions: Drug: Drotrecogin alfa (activated);   Drug: Placebo
11 Completed Study to Compare the Efficacy and Safety of CC-5013 Vs. Placebo in Subjects With Metastatic Malignant Melanoma.
Conditions: Melanoma;   Neoplasm Metastasis
Intervention: Drug: CC-5013
12 Completed Can Resistance Enhance Selection of Treatment? (CREST)
Condition: HIV Infection
Intervention: Device: HIV drug resistance tests based upon genotype testing
13 Active, not recruiting A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: SU011248;   Drug: Placebo
14 Completed Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
Conditions: Thromboembolism;   Arthroplasty, Replacement, Hip
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
15 Recruiting A Study for Patients With Non-Hodgkin's Lymphomas
Conditions: T-Cell Lymphoma;   B-Cell Lymphoma
Intervention: Drug: enzastaurin
16 Recruiting Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
17 Completed Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Condition: Heart Failure, Congestive
Intervention: Drug: Levosimendan
18 Recruiting Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Placebo
19 Recruiting Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: adalimumab;   Biological: placebo
20 Completed Tiotropium / Respimat One-Year Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Tiotropium Inhalation Solution

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services